Literature DB >> 9169344

Regulation of osteoclast function.

T Suda1, I Nakamura, E Jimi, N Takahashi.   

Abstract

Mesh:

Substances:

Year:  1997        PMID: 9169344     DOI: 10.1359/jbmr.1997.12.6.869

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


× No keyword cloud information.
  54 in total

1.  M-CSF neutralization and egr-1 deficiency prevent ovariectomy-induced bone loss.

Authors:  S Cenci; M N Weitzmann; M A Gentile; M C Aisa; R Pacifici
Journal:  J Clin Invest       Date:  2000-05       Impact factor: 14.808

Review 2.  Regulation of osteoclast formation and function.

Authors:  L T Duong; G A Rodan
Journal:  Rev Endocr Metab Disord       Date:  2001-01       Impact factor: 6.514

3.  IL-4 abrogates osteoclastogenesis through STAT6-dependent inhibition of NF-kappaB.

Authors:  Y Abu-Amer
Journal:  J Clin Invest       Date:  2001-06       Impact factor: 14.808

4.  Osteoblast extracellular Ca2+ -sensing receptor regulates bone development, mineralization, and turnover.

Authors:  Melita M Dvorak-Ewell; Tsui-Hua Chen; Nathan Liang; Caitlin Garvey; Betty Liu; Chialing Tu; Wenhan Chang; Daniel D Bikle; Dolores M Shoback
Journal:  J Bone Miner Res       Date:  2011-12       Impact factor: 6.741

Review 5.  Regulation of osteoclast polarization.

Authors:  Naoyuki Takahashi; Sadakazu Ejiri; Shigeru Yanagisawa; Hidehiro Ozawa
Journal:  Odontology       Date:  2007-07-25       Impact factor: 2.634

6.  Trolox prevents osteoclastogenesis by suppressing RANKL expression and signaling.

Authors:  Jong-Ho Lee; Ha-Neui Kim; Daum Yang; Kyoungsuk Jung; Hyun-Man Kim; Hong-Hee Kim; Hyunil Ha; Zang Hee Lee
Journal:  J Biol Chem       Date:  2009-03-19       Impact factor: 5.157

7.  Receptor activator of NF-kappaB ligand (RANKL) activates TAK1 mitogen-activated protein kinase kinase kinase through a signaling complex containing RANK, TAB2, and TRAF6.

Authors:  Junko Mizukami; Giichi Takaesu; Hiroyuki Akatsuka; Hiroaki Sakurai; Jun Ninomiya-Tsuji; Kunihiro Matsumoto; Naoki Sakurai
Journal:  Mol Cell Biol       Date:  2002-02       Impact factor: 4.272

8.  Expression of an estrogen receptor agonist in differentiating osteoblast cultures.

Authors:  Thomas L McCarthy; Mary E Clough; Caren M Gundberg; Michael Centrella
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-12       Impact factor: 11.205

9.  Unusual association between increased bone resorption and presence of paroxysmal nocturnal hemoglobinuria phenotype in multiple myeloma.

Authors:  Evangelos Terpos; Michalis Samarkos; Christos Meletis; Effie Apostolidou; Maria Tsironi; Konstantinos Korovesis; Despina Mavrogianni; Nora Viniou; John Meletis
Journal:  Int J Hematol       Date:  2003-11       Impact factor: 2.490

10.  PYK2 in osteoclasts is an adhesion kinase, localized in the sealing zone, activated by ligation of alpha(v)beta3 integrin, and phosphorylated by src kinase.

Authors:  L T Duong; P T Lakkakorpi; I Nakamura; M Machwate; R M Nagy; G A Rodan
Journal:  J Clin Invest       Date:  1998-09-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.